Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R Mastrangelo

Treatment of Advanced Neuroblastoma: Feasibility and Therapeutic Potential of a Novel Approach Combining 131-I-Mibg and Multiple Drug Chemotherapy

British Journal of Cancer

Cancer Research

Oncology

2001

English

Agar in the Management of Hyperbilirubinaemia in the Premature Baby.

Archives of Disease in Childhood

English

Related publications

Improved Outcome of 131 I-mIBG Treatment Through Combination With External Beam Radiotherapy in the SK-N-SH Mouse Model of Neuroblastoma

Radiotherapy and Oncology

English

Drug Treatment of Tuberculosis: I. Standard Chemotherapy

BMJ

1960

English

Feasibility and Advantage of Adding 131i-Mibg to 90y-Dotatoc for Treatment of Patients With Advanced Stage Neuroendocrine Tumors

English

Analysis of Quantitative [I-123] mIBG SPECT/CT in a Phantom and in Patients With Neuroblastoma

Biomedical Engineering

2019

English

Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study

Journal of Clinical Oncology

English

Hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma

Frontiers in Oncology

Cancer Research

Oncology

2019

English

MIBG in Neuroblastoma Diagnostic Imaging and Therapy

English

Pilot Study of Iodine-131–Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma

Journal of Clinical Oncology

English

Feasibility of Administering High-Dose131I-Mibg Therapy to Children With High-Risk Neuroblastoma Without Lead-Lined Rooms

Pediatric Blood and Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R Mastrangelo

Treatment of Advanced Neuroblastoma: Feasibility and Therapeutic Potential of a Novel Approach Combining 131-I-Mibg and Multiple Drug Chemotherapy

Agar in the Management of Hyperbilirubinaemia in the Premature Baby.

Related publications

Improved Outcome of 131 I-mIBG Treatment Through Combination With External Beam Radiotherapy in the SK-N-SH Mouse Model of Neuroblastoma

Drug Treatment of Tuberculosis: I. Standard Chemotherapy

Feasibility and Advantage of Adding 131i-Mibg to 90y-Dotatoc for Treatment of Patients With Advanced Stage Neuroendocrine Tumors

Analysis of Quantitative [I-123] mIBG SPECT/CT in a Phantom and in Patients With Neuroblastoma

Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study

Hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma

MIBG in Neuroblastoma Diagnostic Imaging and Therapy

Pilot Study of Iodine-131–Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma

Feasibility of Administering High-Dose131I-Mibg Therapy to Children With High-Risk Neuroblastoma Without Lead-Lined Rooms